Literature DB >> 16634643

Substrate-assisted cysteine deprotonation in the mechanism of dimethylargininase (DDAH) from Pseudomonas aeruginosa.

Everett M Stone1, Alison L Costello, David L Tierney, Walter Fast.   

Abstract

The enzyme dimethylargininase (also known as dimethylarginine dimethylaminohydrolase or DDAH; EC 3.5.3.18) catalyzes the hydrolysis of endogenous nitric oxide synthase inhibitors, N(omega)-methyl-l-arginine and N(omega),N(omega)-dimethyl-l-arginine. Understanding the mechanism and regulation of DDAH activity is important for developing ways to control nitric oxide production during angiogenesis and in many cases of vascular endothelial pathobiology. Several possible physiological regulation mechanisms of DDAH depend upon the presence of an active-site cysteine residue, Cys249 in Pseudomonas aeruginosa (Pa) DDAH, which is proposed to serve as a nucleophile in the catalytic mechanism. Through the use of pH-dependent ultraviolet and visible (UV-vis) difference spectroscopy and inactivation kinetics, the pK(a) of the active-site Cys249 in the resting enzyme was found to be unperturbed from pK(a) values of typical noncatalytic cysteine residues. In contrast, the pH dependence of k(cat) values indicates a much lower apparent pK(a) value. UV-vis difference spectroscopy between wild-type and C249S DDAH shows absorbance changes consistent with Cys249 deprotonation to the anionic thiolate upon binding positively charged ligands. The proton from Cys249 is lost either to the solvent or to an unidentified general base. A mutation of the active-site histidine residue, H162G, does not eliminate cysteine nucleophilicity, further arguing against a pre-formed ion pair with Cys249. Finally, UV-vis and X-ray absorption spectroscopy revealed that inhibitory metal ions can bind at these two active-site residues, Cys249 and His162, and also stabilize the anionic form of Cys249. These results support a proposed substrate-assisted mechanism for Pa DDAH in which ligand binding modulates the reactivity of the active-site cysteine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16634643     DOI: 10.1021/bi052595m

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  26 in total

1.  On the mechanism of dimethylarginine dimethylaminohydrolase inactivation by 4-halopyridines.

Authors:  Corey M Johnson; Arthur F Monzingo; Zhihong Ke; Dae-Wi Yoon; Thomas W Linsky; Hua Guo; Jon D Robertus; Walter Fast
Journal:  J Am Chem Soc       Date:  2011-06-23       Impact factor: 15.419

2.  Characterization of C-alkyl amidines as bioavailable covalent reversible inhibitors of human DDAH-1.

Authors:  Matthew Lluis; Yun Wang; Arthur F Monzingo; Walter Fast; Jon D Robertus
Journal:  ChemMedChem       Date:  2011-01-03       Impact factor: 3.466

3.  Promiscuous partitioning of a covalent intermediate common in the pentein superfamily.

Authors:  Thomas W Linsky; Arthur F Monzingo; Everett M Stone; Jon D Robertus; Walter Fast
Journal:  Chem Biol       Date:  2008-05

4.  Developing dual and specific inhibitors of dimethylarginine dimethylaminohydrolase-1 and nitric oxide synthase: toward a targeted polypharmacology to control nitric oxide.

Authors:  Yun Wang; Arthur F Monzingo; Shougang Hu; Tera H Schaller; Jon D Robertus; Walter Fast
Journal:  Biochemistry       Date:  2009-09-15       Impact factor: 3.162

Review 5.  Chemical biology of protein arginine modifications in epigenetic regulation.

Authors:  Jakob Fuhrmann; Kathleen W Clancy; Paul R Thompson
Journal:  Chem Rev       Date:  2015-05-13       Impact factor: 60.622

6.  Crystal structures and biochemical analyses of the bacterial arginine dihydrolase ArgZ suggests a "bond rotation" catalytic mechanism.

Authors:  Ningning Zhuang; Hao Zhang; Lingting Li; Xiaoxian Wu; Chen Yang; Yu Zhang
Journal:  J Biol Chem       Date:  2019-12-30       Impact factor: 5.157

7.  Screening for dimethylarginine dimethylaminohydrolase inhibitors reveals ebselen as a bioavailable inactivator.

Authors:  Thomas Linsky; Yun Wang; Walter Fast
Journal:  ACS Med Chem Lett       Date:  2011       Impact factor: 4.345

8.  Born-Oppenheimer ab initio QM/MM molecular dynamics simulations of the hydrolysis reaction catalyzed by protein arginine deiminase 4.

Authors:  Zhihong Ke; Shenglong Wang; Daiqian Xie; Yingkai Zhang
Journal:  J Phys Chem B       Date:  2009-12-31       Impact factor: 2.991

9.  Haloacetamidine-based inactivators of protein arginine deiminase 4 (PAD4): evidence that general acid catalysis promotes efficient inactivation.

Authors:  Bryan Knuckley; Corey P Causey; Perry J Pellechia; Paul F Cook; Paul R Thompson
Journal:  Chembiochem       Date:  2010-01-25       Impact factor: 3.164

10.  Protein arginine deiminase 4: evidence for a reverse protonation mechanism.

Authors:  Bryan Knuckley; Monica Bhatia; Paul R Thompson
Journal:  Biochemistry       Date:  2007-05-12       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.